Review



subcutaneous glucose sensing dexcom seven plus sensors  (Dexcom Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Dexcom Inc subcutaneous glucose sensing dexcom seven plus sensors
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Subcutaneous Glucose Sensing Dexcom Seven Plus Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous glucose sensing dexcom seven plus sensors/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous glucose sensing dexcom seven plus sensors - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance"

    Article Title: A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance

    Journal: Journal of process control

    doi: 10.1016/j.jprocont.2019.01.002

    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with subcutaneous sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Figure Legend Snippet: Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with subcutaneous sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).

    Techniques Used: Comparison



    Similar Products

    90
    Dexcom Inc subcutaneous glucose sensing dexcom seven plus sensors
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Subcutaneous Glucose Sensing Dexcom Seven Plus Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous glucose sensing dexcom seven plus sensors/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous glucose sensing dexcom seven plus sensors - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous cgm sensor seven plus
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Subcutaneous Cgm Sensor Seven Plus, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous cgm sensor seven plus/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous cgm sensor seven plus - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc seven plus subcutaneous sensor
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Seven Plus Subcutaneous Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/seven plus subcutaneous sensor/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    seven plus subcutaneous sensor - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous glucose sensor seven plus
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Subcutaneous Glucose Sensor Seven Plus, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous glucose sensor seven plus/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous glucose sensor seven plus - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous glucose sensors dexcom seven plus
    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with <t>subcutaneous</t> sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).
    Subcutaneous Glucose Sensors Dexcom Seven Plus, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous glucose sensors dexcom seven plus/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous glucose sensors dexcom seven plus - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous dexcom seven plus sensors
    A frequency histogram of sensor accuracy (ARD) obtained in <t>subcutaneous</t> amperometric sensors (Dexcom® <t>SEVEN®</t> <t>PLUS)</t> in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.
    Subcutaneous Dexcom Seven Plus Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous dexcom seven plus sensors/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous dexcom seven plus sensors - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous amperometric sensors dexcom® seven® plus
    A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous <t>amperometric</t> sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.
    Subcutaneous Amperometric Sensors Dexcom® Seven® Plus, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous amperometric sensors dexcom® seven® plus/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous amperometric sensors dexcom® seven® plus - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Dexcom Inc subcutaneous sensor seven plus
    Devices currently available for home continuous glucose monitoring.
    Subcutaneous Sensor Seven Plus, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/subcutaneous sensor seven plus/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    subcutaneous sensor seven plus - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with subcutaneous sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).

    Journal: Journal of process control

    Article Title: A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance

    doi: 10.1016/j.jprocont.2019.01.002

    Figure Lengend Snippet: Closed-loop robustness analysis of the proposed IP-IP controller (green) vs. the proposed IP-SC controller with subcutaneous sensing (red), and the IP-IP PID controller (black) designed by Huyett et al 24. [A] Median glucose trajectories in mg/dL with unannounced meals (inverted cyan triangles) and effect of exercise input (red triangle). Set point is at 110 mg/dL. [B] Corresponding median insulin delivery in U/5 min. [C] Comparison of the percent time in hypoglycemia (< 70 mg/dL). [D] Comparison of the percent time in glycemic safe zone (within 70–180 mg/dL). [E] Comparison of the percent time in hyperglycemia (>180 mg/dL).

    Article Snippet: Ten adults (7 male, 3 female) with T1DM participated in a non-randomized, non-blinded sequential AP study ‡ using subcutaneous glucose sensing via Dexcom Seven Plus sensors (Dexcom, San Diego, USA) and zone MPC modified[ 31 ] for IP delivery via the Diaport system (Second Generation, Roche Diagnostics, Mannheim, Germany).

    Techniques: Comparison

    A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.

    Journal: Journal of Diabetes Science and Technology

    Article Title: Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia

    doi:

    Figure Lengend Snippet: A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.

    Article Snippet: Each subject had two subcutaneous Dexcom SEVEN PLUS sensors.

    Techniques: Control

    (A) A frequency histogram obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in 14 persons with T1DM, each during 66 hours of closed-loop monitoring and treatment. Each subject had two subcutaneous Dexcom SEVEN PLUS sensors. At each time point, simple sensor error was measured (sensor glucose – venous reference Hemocue glucose) in a random sensor (blue) and the average of the two sensors (red). Note Gaussian distribution of both data sets with very low skewness coefficients, indicating symmetry. There was a slight negative bias of –8.5–10 mg/dl for both data sets. (B) The same frequency histogram as in Figure 4A, now plotted on an expanded y-axis in order to discriminate better between the distribution of random versus average data values. Especially at the tails, the average values have a substantially lower error than the random sensor values. For averaged values, there were only 1.2% of values that were either less than -60 mg/dl or greater than 60 mg/dl (as compared to 2.7% of the randomly chosen values).

    Journal: Journal of Diabetes Science and Technology

    Article Title: Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia

    doi:

    Figure Lengend Snippet: (A) A frequency histogram obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in 14 persons with T1DM, each during 66 hours of closed-loop monitoring and treatment. Each subject had two subcutaneous Dexcom SEVEN PLUS sensors. At each time point, simple sensor error was measured (sensor glucose – venous reference Hemocue glucose) in a random sensor (blue) and the average of the two sensors (red). Note Gaussian distribution of both data sets with very low skewness coefficients, indicating symmetry. There was a slight negative bias of –8.5–10 mg/dl for both data sets. (B) The same frequency histogram as in Figure 4A, now plotted on an expanded y-axis in order to discriminate better between the distribution of random versus average data values. Especially at the tails, the average values have a substantially lower error than the random sensor values. For averaged values, there were only 1.2% of values that were either less than -60 mg/dl or greater than 60 mg/dl (as compared to 2.7% of the randomly chosen values).

    Article Snippet: Each subject had two subcutaneous Dexcom SEVEN PLUS sensors.

    Techniques:

    A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.

    Journal: Journal of Diabetes Science and Technology

    Article Title: Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia

    doi:

    Figure Lengend Snippet: A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies. Sensors were calibrated every 6 h with arterialized venous blood using a very accurate glucose measurement device (Hemocue 201). Although mean ARD indicates very good accuracy, it should be noted that a small percentage of readings indicate poor sensor accuracy that may lead to insulin delivery errors during closed-loop treatment. CGM, continuous glucose monitoring; BG, blood glucose.

    Article Snippet: With the use of standard outpatient glucose meters as the calibrating instrument, there would undoubtedly be a greater number of large sensor errors. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window caption a7 A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies.

    Techniques: Control

    (A) A frequency histogram obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in 14 persons with T1DM, each during 66 hours of closed-loop monitoring and treatment. Each subject had two subcutaneous Dexcom SEVEN PLUS sensors. At each time point, simple sensor error was measured (sensor glucose – venous reference Hemocue glucose) in a random sensor (blue) and the average of the two sensors (red). Note Gaussian distribution of both data sets with very low skewness coefficients, indicating symmetry. There was a slight negative bias of –8.5–10 mg/dl for both data sets. (B) The same frequency histogram as in Figure 4A, now plotted on an expanded y-axis in order to discriminate better between the distribution of random versus average data values. Especially at the tails, the average values have a substantially lower error than the random sensor values. For averaged values, there were only 1.2% of values that were either less than -60 mg/dl or greater than 60 mg/dl (as compared to 2.7% of the randomly chosen values).

    Journal: Journal of Diabetes Science and Technology

    Article Title: Safe Glycemic Management during Closed-Loop Treatment of Type 1 Diabetes: The Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia

    doi:

    Figure Lengend Snippet: (A) A frequency histogram obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in 14 persons with T1DM, each during 66 hours of closed-loop monitoring and treatment. Each subject had two subcutaneous Dexcom SEVEN PLUS sensors. At each time point, simple sensor error was measured (sensor glucose – venous reference Hemocue glucose) in a random sensor (blue) and the average of the two sensors (red). Note Gaussian distribution of both data sets with very low skewness coefficients, indicating symmetry. There was a slight negative bias of –8.5–10 mg/dl for both data sets. (B) The same frequency histogram as in Figure 4A, now plotted on an expanded y-axis in order to discriminate better between the distribution of random versus average data values. Especially at the tails, the average values have a substantially lower error than the random sensor values. For averaged values, there were only 1.2% of values that were either less than -60 mg/dl or greater than 60 mg/dl (as compared to 2.7% of the randomly chosen values).

    Article Snippet: With the use of standard outpatient glucose meters as the calibrating instrument, there would undoubtedly be a greater number of large sensor errors. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window caption a7 A frequency histogram of sensor accuracy (ARD) obtained in subcutaneous amperometric sensors (Dexcom® SEVEN® PLUS) in persons with T1DM during closed-loop glycemic control studies.

    Techniques:

    Devices currently available for home continuous glucose monitoring.

    Journal: Sensors (Basel, Switzerland)

    Article Title: Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices

    doi: 10.3390/s101210936

    Figure Lengend Snippet: Devices currently available for home continuous glucose monitoring.

    Article Snippet: SEVEN , Dexcom Inc. , Subcutaneous sensor , Yes , No.

    Techniques: